EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische StudieOpen Access

Nonoperative Management of Mismatch Repair–Deficient Tumors

Andrea Cercek, Michael B Foote, Benoit Rousseau, J Joshua Smith, Jinru Shia, Jenna Sinopoli, Jill Weiss, Melissa Lumish iD, Lindsay Temple, Miteshkumar Patel, Callahan Wilde, Leonard B Saltz und 36 weitere

New England Journal of Medicine · 19.06.2025 · 392 (23) · 2297-2308

DOI: 10.1056/nejmoa2404512 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 19.06.2025. Verfasst von Andrea Cercek und 47 weiteren Autor:innen. Beteiligte Einrichtung: Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York. Hauptthemen laut MEDLINE: DNA Mismatch Repair, Immune Checkpoint Inhibitors, Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 258-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Mismatch RepairImmune Checkpoint InhibitorsNeoadjuvant TherapyRectal NeoplasmsNeoplasm Recurrence, LocalAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm StagingProgrammed Cell Death 1 ReceptorDisease-Free SurvivalNeoplasm, ResidualAntibodies, Monoclonal, HumanizedChemoradiotherapy, AdjuvantCapecitabine

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptordostarlimabAntibodies, Monoclonal, HumanizedCapecitabine

Autor:innen und Institutionen

  • Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York.
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York.
  • Department of Oncology, Case Comprehensive Cancer Center, Cleveland.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York.
  • Department of Oncology, Hartford HealthCare, Hartford, CT.

ORCID-Profile: Melissa Lumish

Förderung

  • NCI NIH HHS

Zitieren

APA

Cercek, A., Foote, M. B., Rousseau, B., Smith, J. J., Shia, J., Sinopoli, J., Weiss, J., Lumish, M., Temple, L., Patel, M., Wilde, C., Saltz, L. B., Argiles, G., Stadler, Z., Artz, O., Maron, S., Ku, G., Gu, P., Janjigian, Y. Y., …, & Diaz, L. A. (2025). Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine, 392(23), 2297-2308. https://doi.org/10.1056/nejmoa2404512

Vancouver

Cercek A, Foote MB, Rousseau B, Smith JJ, Shia J, Sinopoli J, et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine. 2025;392(23):2297-2308. doi:10.1056/nejmoa2404512

BibTeX
@article{Cercek2025,
  author = {Cercek, Andrea and Foote, Michael B and Rousseau, Benoit and Smith, J Joshua and Shia, Jinru and Sinopoli, Jenna and Weiss, Jill and Lumish, Melissa and Temple, Lindsay and Patel, Miteshkumar and Wilde, Callahan and Saltz, Leonard B and Argiles, Guillem and Stadler, Zsofia and Artz, Oliver and Maron, Steven and Ku, Geoffrey and Gu, Ping and Janjigian, Yelena Y and Molena, Daniela and Iyer, Gopa and Coleman, Jonathan and Abida, Wassim and Cohen, Seth and Soares, Kevin and Schattner, Mark and Strong, Vivian E and Yaeger, Rona and Paty, Philip and Shcherba, Marina and Sugarman, Ryan and Romesser, Paul B and Zervoudakis, Alice and Desai, Avni and Segal, Neil H and El Dika, Imane and Widmar, Maria and Wei, Iris and Pappou, Emmanouil and Fumo, Gerard and Aparo, Santiago and Gonen, Mithat and Gollub, Marc and Jayaprakasam, Vetri S and Kim, Tae-Hyung and Garcia Aguilar, Julio and Weiser, Martin and Diaz, Luis A},
  title = {Nonoperative Management of Mismatch Repair–Deficient Tumors},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {23},
  pages = {2297--2308},
  doi = {10.1056/nejmoa2404512}
}
Kostenlos starten →